Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Brody

Showing results (511-520 of 517) with videos related to

Pageof 52
Sort By:
You have reached the last page of results.This site can display upto 517 results.
Molecular Cancer Research : MCR|June 6, 2019
The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma CellsErika Parasido, George S Avetian, Aisha Naeem, et al.
Nature Cancer|June 10, 2022
Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitorsAli Vaziri-Gohar, Joel Cassel, Farheen S Mohammed, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2015
Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAsEric Londin, Phillipe Loher, Aristeidis G Telonis, et al.
Nature Cancer|January 9, 2025
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancerJason M Link, Jennifer R Eng, Carl Pelz, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathwayMotoyuki Tsuda, Dove Keith, Colin J Daniel, et al.
Cancer Discovery|June 2, 2018
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic CancerHervé Tiriac, Pascal Belleau, Dannielle D Engle, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
HLA-E and NKG2A Mediate Resistance to <i>M. bovis</i> BCG Immunotherapy in Non-Muscle-Invasive Bladder CancerD Ranti, H Yu, Y A Wang, et al.
Pageof 52

Showing results (511-520 of 517) with videos related to

Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 517 results.
Molecular Cancer Research : MCR|June 6, 2019
The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma CellsErika Parasido, George S Avetian, Aisha Naeem, et al.
Nature Cancer|June 10, 2022
Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitorsAli Vaziri-Gohar, Joel Cassel, Farheen S Mohammed, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2015
Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAsEric Londin, Phillipe Loher, Aristeidis G Telonis, et al.
Nature Cancer|January 9, 2025
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancerJason M Link, Jennifer R Eng, Carl Pelz, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathwayMotoyuki Tsuda, Dove Keith, Colin J Daniel, et al.
Cancer Discovery|June 2, 2018
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic CancerHervé Tiriac, Pascal Belleau, Dannielle D Engle, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
HLA-E and NKG2A Mediate Resistance to <i>M. bovis</i> BCG Immunotherapy in Non-Muscle-Invasive Bladder CancerD Ranti, H Yu, Y A Wang, et al.
Pageof 52